Privia Health Group Target Price

Analysts' average 12-month price target for Privia Health Group is $32.

Get informed when a big investor buys or sells

+ Follow

Share Price

$22.16

Average Target Price

$32.00

44.4% upside

1 analysts in the last 4 months

High: $32 | Low: $32

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	Canaccord Genuity	$32	44.4% upside
2026-05-26	BarclaysAndrew Mok	$24	8.3% upside
2026-04-08	Evercore ISI	$26	17.3% upside
2026-02-26	JefferiesJack Slevin	$32	44.4% upside
2026-02-26	Piper SandlerJessica Tassan	$36	62.5% upside
2026-01-09	RBC Capital	$31	39.9% upside
2026-01-06	Wolfe Research	$31	39.9% upside
2025-11-12	Canaccord Genuity	$34	53.4% upside
2025-10-09	Barclays	$22	0.7% downside
2025-08-29	JMP Securities	$30	35.4% upside
2025-04-15	Robert W. BairdMichael Ha	$26	17.3% upside
2025-02-28	JMP Securities	$29	30.9% upside
2025-02-28	Piper Sandler	$40	80.5% upside
2025-02-28	Canaccord Genuity	$30	35.4% upside
2025-01-10	NeedhamMatthew Shea	$25	12.8% upside
2024-08-26	Robert W. BairdMichael Ha	$24	8.3% upside
2024-08-08	Evercore ISIElizabeth Anderson	$22	0.7% downside
2024-05-20	BarclaysAndrew Mok	$19	14.3% downside
2024-05-15	Truist FinancialJailendra Singh	$24	8.3% upside
2022-12-08	UBS	$30	35.4% upside
2022-11-17	Canaccord GenuityCanaccord Canaccord	$43	94% upside
2022-11-11	Leerink Partners	$39	76% upside
2022-08-25	Canaccord Genuity	$50	125.6% upside
2022-08-12	Truist Financial	$48	116.6% upside
2022-08-12	Credit Suisse	$41	85% upside
2022-08-12	Cowen & Co.	$44	98.6% upside
2022-08-12	GuggenheimSandy Draper	$51	130.1% upside
2022-08-12	Leerink Partners	$46	107.6% upside
2022-07-25	Truist FinancialDavid MacDonald	$40	80.5% upside
2022-05-13	Canaccord Genuity	$29	30.9% upside
2022-04-28	BTIG	$35	57.9% upside

Privia Health Group (PRVA) FAQ

The latest target price for PRVA is $32. Investors often review this figure alongside Privia Health Group's historical trend and sector peers before judging valuation or financial health.

Privia Health Group trades near $22.16 while the consensus target sits at $32 (44.4% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting PRVA's target price ($32), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Privia Health Group's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.